Sun Pharmaceutical Drugs Recall Of Over 1.10 Lakh Bottles Of Generic Drugs In US Market | Udaipur News | Latest news from Udaipur


Sun Pharmaceutical Industries is currently trading at Rs. 777.10, down 13.35 points or 1.69% from its previous close of Rs. 790.45 on BSE.

The script opened at Rs. 790.10 and hit a high and low of Rs. 794.20 and Rs. 776.25 respectively. So far, 19,682 shares have been traded over the counter.

ESB Group ‘A’ stock with a face value of Rs. 1 hit a 52-week high of Rs. 850.00 on 18-Oct-2021 and a 52-week low of Rs. 496.05 on 20- Nov-2020.

Last week the top and bottom of the script stood at Rs. 819.80 and Rs. 776.25 respectively. The current market capitalization of the company is Rs. 187,963.90 crore.

The promoters’ stake in the company amounted to 54.48%, while Institutions and Non-Institutions respectively held 33.80% and 11.72%.

Sun Pharmaceutical Industries is recalling over 1.10 lakh bottles of a generic drug used to treat erectile dysfunction in men from the US market due to a manufacturing error. The US branch of the national pharmaceutical major is recalling Tadalafil tablets from the US market, according to the latest application report from the United States Food and Drug Administration (USFDA). The company is recalling the product in 30-dose vials of 5 mg and 20 mg.

The company is recalling 73,957 5 mg bottles and 36,786 20 mg bottles. An affected batch of the drug was manufactured by the drug maker in India and distributed in the United States by Sun Pharmaceutical Industries Inc, based in Princeton, New Jersey.

Sun Pharma is the world’s fourth largest generic specialty pharmaceutical company and India’s leading pharmaceutical company.

Source link


Comments are closed.